Malene B. Hansen
Glostrup, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Residual inflammation in the cerebrospinal fluid after short- and long-term natalizumab treatment in relapsing-remitting multiple sclerosis.
Journal: Frontiers in immunology
Published: February 25, 2026
Cerebrospinal Fluid sCD27 as a Biomarker of Neuroinflammatory Disease: A Systematic Review and Meta-Analysis.
Journal: Journal of neurochemistry
Published: November 26, 2025
Profiling of Epstein-Barr Virus microRNAs in Whole Blood and Exosomes in Multiple Sclerosis.
Journal: Immunological investigations
Published: October 01, 2025
Cerebrospinal fluid exosomal Epstein-Barr virus microRNAs in multiple sclerosis and effects of disease modifying therapies.
Journal: Clinical immunology (Orlando, Fla.)
Published: July 25, 2025
Serum GFAP and NfL levels in migraine: A registry for migraine (REFORM) study.
Journal: Cephalalgia : an international journal of headache
Published: May 23, 2025
A role for DICAM+ mononuclear phagocytes in controlling neuroinflammation in multiple sclerosis.
Journal: Frontiers in immunology
Published: May 14, 2025
Corrigendum to "Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis" [Journal of neuroimmunology vol. 381 (2023): 578128].
Journal: Journal of neuroimmunology
Published: April 11, 2025
Mononuclear phagocytes in blood and cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis: Untreated and treated with anti-CD20 therapy.
Journal: Journal of neuroimmunology
Published: April 08, 2025
Effects of anti-CD20 therapy on circulating and intrathecal follicular helper T cell subsets in multiple sclerosis.
Journal: Clinical immunology (Orlando, Fla.)
Published: February 28, 2024
Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness.
Journal: Alzheimer's & dementia (Amsterdam, Netherlands)
Published: August 11, 2023
Cerebrospinal fluid soluble CD27 is associated with CD8+ T cells, B cells and biomarkers of B cell activity in relapsing-remitting multiple sclerosis.
Journal: Journal of neuroimmunology
Published: May 03, 2023
Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response.
Journal: European journal of neurology
Published: January 04, 2023
Last Updated: 09/26/2026